{"line_no":1,"decision":"edit","rationale":"Condensed platelet-vs-factor overview into high-yield diagnostic split with preserved clinical pattern logic.","input_sha256":"30df959ccca8fd76c94ee41f2c731ab2f96abd86505107b2b8526d86141d6b41","output_sha256":"b930a7ea27b168fe4393dde8deba63d315b58c274e46967d0c0607bbb00ad62e"}
{"line_no":2,"decision":"edit","rationale":"Kept pseudothrombocytopenia, mixing-study interpretation, and neonatal/antibiotic vitamin K pathways.","input_sha256":"2136e32f409f49b04ace38499ed2b3d6140993eff308789de3a8e04e7d47a910","output_sha256":"fc75898e4f11139f7defee233b6a2477c2bfe30b18f887aa5c6757c719036db4"}
{"line_no":3,"decision":"edit","rationale":"Rebuilt ITP and TTP sections into mechanism-diagnosis-treatment algorithms with adult HIV/HCV exclusion note.","input_sha256":"0a05db347fe11e046dc11fbcdc4306a016003a79a5639606c01fb62af3283ee6","output_sha256":"c26a783d2a8d3ea546813475dc1b841241ee26a13b122c0516b7c3a18d8dbac1"}
{"line_no":4,"decision":"edit","rationale":"Preserved TTP-HUS differentiation and critical contraindications (platelets in TTP, antibiotics in STEC-HUS).","input_sha256":"84c330ffb3938b7fb81bb01b56a1350dfea6359003d0a0043c100ed7462dc825","output_sha256":"651436d4d346a1bad27ce962dfc87335081107a8bc3227f082b5de3882ba3766"}
{"line_no":5,"decision":"edit","rationale":"Converted extended recap into compact condition-action table while retaining key pearls.","input_sha256":"377d696e474e4ce5b47c4ae1163cdec3b25d90fd56b58168b849cef6d2a31197","output_sha256":"221f0b12e436becb65b35b0d4939034369314e8798e69e623a38627e9c1a420d"}
{"line_no":6,"decision":"edit","rationale":"Normalized second hemostasis tree into cleaner primary/secondary branch framework.","input_sha256":"f08c2c664c23ab62e7d86e40194f0400315c49d31a1dcc04e508f546aae7515d","output_sha256":"ba1ede2f547f8c2c57f08ec4b6bf954b275365a9c4cd3383e195d0033f05404c"}
{"line_no":7,"decision":"edit","rationale":"Integrated MAHA razor-wire concept with TTP/HUS/ITP management without narrative filler.","input_sha256":"13458e26ad9b7115cf8c39011441def0bccaf9a08f4075759eaaae863ff5b310","output_sha256":"612cc94cabe79ff6bdb3dee121c053c87a90cfcccec37f863a0145ceb8f8adc5"}
{"line_no":8,"decision":"edit","rationale":"Retained ITP treatment thresholds, mixing-study table, lupus anticoagulant paradox, and DIC overview.","input_sha256":"c2d7ede5b5f23411c34518b5ca1a6593976674689d1eeb2c406b6413ca751361","output_sha256":"24567e4db70bebb0074b329857a6e473949c3e5d831b037343320cb4d930a91b"}
{"line_no":9,"decision":"edit","rationale":"Preserved DIC acute/chronic distinction and reversal-agent table with vitamin K context.","input_sha256":"1768803adee089caa1277db14bb9d721357d3c773099295e5d2f9fda2779ac2a","output_sha256":"d47b0d20ccabdafac972218df00140e3de51fcc1e01996a706c6157230d1bdd0"}
{"line_no":10,"decision":"edit","rationale":"Trimmed recap and transition chatter while keeping reversal and mixing-study high-yield rules.","input_sha256":"3485fd4d5e9625cb8d7b36766a42d40c69f1a4cd6bf822577415dd42fc18ac4f","output_sha256":"9f9bde0825925d8332c7c1402f08e3348612caf55e4e1f17526bf8105fe32266"}
{"line_no":11,"decision":"edit","rationale":"Reframed oncology complications into acute-vs-late effects with exposure-based survivorship risks.","input_sha256":"c3747929d9d43af1cc0f6e0afe584593f1b92cca2853f3fed7b2fba2a89f3045","output_sha256":"476610c179a56b0d20b208d10e3b3bb3116de3ef4db2bf5cb02c847f9f67968a"}
{"line_no":12,"decision":"edit","rationale":"Preserved cardiotoxicity distinctions, myeloma imaging trap, TLS pathway, and rasburicase G6PD warning.","input_sha256":"8ca849db71a567bb9146d950bd54abd9279205505786c64279257cbcc50af834","output_sha256":"88f1fadb6967b39763b40de1ef0b80f69e297f60ad707416c58600675fc36f6f"}
{"line_no":13,"decision":"edit","rationale":"Converted mixed recap text to structured survivorship/crisis-management action table and removed quiz prompts.","input_sha256":"e3994fd7fe39599250d86ae68f61baa4a23fe760b33c99b5c5323e34c7a2cfe5","output_sha256":"861c1e3a05dbfa13168ba72bed4f94b5dc598175c63c0967e833c4718eab7146"}
